Please try another search
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. The company provides Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer’s, Parkinson's, and SARS-CoV-2; PharmaKG, a biomedical knowledge graph; and Disease Diagnosis and Risk Assessment Platform. The company was founded in 2014 and is based in Berlin, Germany.
Name | Age | Since | Title |
---|---|---|---|
Wade Menpes-Smith | - | - | Chairman of the Board, CEO & MD |
David C. Rubinsztein | - | 2020 | Member of Drug Discovery Advisory Board & Chief Scientific Advisor |
Geir Selbæk | - | 2019 | Member of Drug Discovery Advisory Board & Adviser of Biobank |
Henrik Schirmer | - | 2019 | Member of Drug Advisory Board & Adviser of Cardiovascular |
Guang Yang | - | 2019 | Member of Drug Discovery Advisory Board & Adviser of Medical Imaging |
Evandro F. Fang | - | 2019 | Member of Early Diagnosis Advisory Board & Adviser of Early Stage Drug Discovery |
Hilde Loge Nilsen | - | 2019 | Member of Early Diagnosis Advisory Board & Adviser of Biological Research |
Linda Hildegard Bergersen | - | 2019 | Member of Early Diagnosis Advisory Board & Adviser of Aging |
Jon Storm-Mathisen | - | 2019 | Member of Drug Advisory Board & Adviser of Neurological Research |
Hamish Badenoch | - | 2020 | CFO & Director |
Bimal Shah | - | - | Deputy Chairman & COO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review